[尿剂耐药性和心力衰竭:在塞和损伤之间]
1Instituto Argentino de Diagnóstico y Tratamiento. Buenos Aires, Argentina.
Archivos peruanos de cardiologia y cirugia cardiovascular
|December 13, 2023
概括
在急性心力衰竭 (HF) 中,尿液耐药性是一个重大挑战. 了解和治疗这种耐药性对于改善HF管理中的患者结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病综合征是什么心脏病综合征
背景情况:
- 心力衰竭 (HF) 显著导致心血管疾病和死亡率.
- 心脏综合征 (CRS) 强调了复杂的心脏相互作用.
- 急性HF的利尿剂耐药性预测不良事件,独立于功能.
研究的目的:
- 评估急性心力衰竭中利尿剂耐药性的原因和影响.
- 探索拥堵在心脏脏综合征病理生理学的作用.
- 解决临床问题,即是否对利尿剂耐药性的干预措施会影响急性HF的预后.
主要方法:
- 对抗利尿剂多因素原因的综合评估.
- 分析拥堵在延续心脏和损伤中的作用.
- 对急性HF尿素耐药性的当前治疗策略的审查.
主要成果:
- 利尿剂耐药性是一个复杂的问题,有多种促成因素.
- 拥堵在心脏脏综合征中起着关键的双向作用.
- 目前在HF中使用的利尿剂在很大程度上是经验性的,缺乏有力的证据.
结论:
- 需要进一步的研究,以建立基于证据的治疗方法,以治疗急性HF的利尿剂耐药性.
- 针对利尿剂耐药性的干预措施可能是改善HF预后的关键.
- 更深入地了解心脏和脏相互作用对于有效的高频率管理至关重要.
相关概念视频
Heart Failure Drugs: Diuretics
395
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
395
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Antihypertensive Drugs: Action of Diuretics
782
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
782
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
Antihypertensive Drugs: Potassium-Sparing Diuretics
578
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
578


